JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $580 | -100.0% | 522,578 | -34.7% | 0.00% | -71.4% |
| Q3 2022 | $1,873,000 | -54.9% | 800,291 | -41.6% | 0.01% | -53.3% |
| Q2 2022 | $4,155,000 | -58.2% | 1,371,391 | -6.3% | 0.02% | -46.4% |
| Q1 2022 | $9,943,000 | +458.9% | 1,464,332 | +587.4% | 0.03% | +460.0% |
| Q4 2021 | $1,779,000 | +12.4% | 213,019 | -0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,583,000 | -65.9% | 213,043 | -68.8% | 0.01% | -68.8% |
| Q2 2021 | $4,644,000 | +352.6% | 682,870 | +229.6% | 0.02% | +100.0% |
| Q2 2019 | $1,026,000 | -40.5% | 207,200 | -25.5% | 0.01% | -50.0% |
| Q1 2019 | $1,724,000 | +964.2% | 278,100 | +479.5% | 0.02% | +700.0% |
| Q4 2018 | $162,000 | – | 47,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |